Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Monica Pinheiro de Almeida Verissimo, Sandra Regina Loggetto, Antonio Fabron Junior, Giorgio Roberto Baldanzi, Nelson Hamerschlak, Juliano Lara Fernandes, Aderson da Silva Araujo, Clarisse Lopes de Castro Lobo, Kleber Yotsumoto Fertrin, Vasilios Antonios Berdoukas, Renzo Galanello
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2013-01-01
Serie:	Revista Brasileira de Hematologia e Hemoterapia
Soggetti:	Blood transfusion Chelation therapy Deferiprone Deferasirox Iron/metabolism beta-Thalassemia Iron overload Iron chelating agents Magnetic resonance imaging Practice guidelines as topic Protocols Brazil
Accesso online:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000600428&lng=en&tlng=en
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!